Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain.
An enigmatic feature of behavioural state control is the rich diversity of wake-promoting neural systems. This diversity has been rationalized as 'robustness via redundancy', wherein wakefulness control is not critically dependent on one type of neuron or molecule. Studies of the brain orexin/hypocretin system challenge this view by demonstrating that wakefulness control fails upon loss of this neurotransmitter system. Since orexin neurons signal arousal need, and excite other wake-promoting neurons, their actions illuminate nonredundant principles of arousal control. Here, we suggest such principles by reviewing the orexin system from a collective viewpoint of biology, physics and engineering. Orexin peptides excite other arousal-promoting neurons (noradrenaline, histamine, serotonin, acetylcholine neurons), either by activating mixed-cation conductances or by inhibiting potassium conductances. Ohm's law predicts that these opposite conductance changes will produce opposite effects on sensitivity of neuronal excitability to current inputs, thus enabling orexin to differentially control input-output gain of its target networks. Orexin neurons also produce other transmitters, including glutamate. When orexin cells fire, glutamate-mediated downstream excitation displays temporal decay, but orexin-mediated excitation escalates, as if orexin transmission enabled arousal controllers to compute a time integral of arousal need. Since the anatomical and functional architecture of the orexin system contains negative feedback loops (e.g. orexin ➔ histamine ➔ noradrenaline/serotonin-orexin), such computations may stabilize wakefulness via integral feedback, a basic engineering strategy for set point control in uncertain environments. Such dynamic behavioural control requires several distinct wake-promoting modules, which perform nonredundant transformations of arousal signals and are connected in feedback loops.
Department of Neurology, University of Bern, Bern University Hospital, 3010, Bern, Switzerland.
Cornelia
C
Schöne
The Francis Crick Institute, Mill Hill Laboratory, London, NW7 1AA, UK. denis.burdakov@crick.ac.uk.
Denis
D
Burdakov
D000818:Animals; D001921:Brain / Q000378:metabolism*; D006801:Humans; D009474:Neurons / Q000378:metabolism*; D000068797:Orexins / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D014851:Wakefulness / Q000502:physiology*
D000068797:Orexins
Arousal; Brain state; Control theory; Hypocretin; Hypothalamus; Neurons; Orexin